JNJ vs. EMR

Last updated Jun 4, 2026

JNJ (Johnson & Johnson) and EMR (Emerson Electric Co.) are both stocks. JNJ operates in Drug Manufacturers - General (Healthcare), while EMR operates in Specialty Industrial Machinery (Industrials). Over the past 10 years, JNJ returned 9.85%/yr vs 13.21%/yr for EMR. At a 0.31 correlation, their price movements are largely independent.

Performance

JNJ vs. EMR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Johnson & Johnson (JNJ) and Emerson Electric Co. (EMR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, JNJ achieves a 9.07% return, which is significantly higher than EMR's 6.99% return. Over the past 10 years, JNJ has underperformed EMR with an annualized return of 9.85%, while EMR has yielded a comparatively higher 13.21% annualized return.

JNJ

• 1D: 0.16%
• 1M: 0.14%
• YTD: 9.07%
• 6M: 9.93%
• 1Y: 48.18%
• 3Y*: 15.79%
• 5Y*: 9.14%
• 10Y*: 9.85%

EMR

• 1D: -0.81%
• 1M: 4.42%
• YTD: 6.99%
• 6M: 5.27%
• 1Y: 18.92%
• 3Y*: 21.58%
• 5Y*: 9.66%
• 10Y*: 13.21%

*Multi-year figures are annualized to reflect compound growth (CAGR)

JNJ vs. EMR - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
JNJ Johnson & Johnson	9.07%	47.48%	-4.81%	-8.58%	5.97%	11.44%	10.82%	16.22%	-5.13%	24.43%
EMR Emerson Electric Co.	6.99%	8.92%	29.73%	3.75%	5.74%	18.19%	8.61%	31.53%	-11.87%	29.05%

Correlation

The correlation between JNJ and EMR is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.08
Correlation (3Y) Calculated over the trailing 3-year period	0.07
Correlation (5Y) Calculated over the trailing 5-year period	0.17
Correlation (10Y) Calculated over the trailing 10-year period	0.25
Correlation (All Time) Calculated using the full available price history since Jun 2, 1972	0.31

Over the past year, the correlation between JNJ and EMR has dropped to 0.08 - well below their long-term average of 0.31, suggesting their price drivers have been diverging.

Fundamentals

Market Cap JNJ : $545.87B EMR : $79.32B
EPS JNJ : $8.65 EMR : $4.33
PE Ratio JNJ : 25.81 EMR : 32.52
PEG Ratio JNJ : 0.86 EMR : 11.56
PS Ratio JNJ : 5.64 EMR : 4.34
PB Ratio JNJ : 6.72 EMR : 3.90
Total Revenue (TTM) JNJ : $96.36B EMR : $18.32B
Gross Profit (TTM) JNJ : $66.60B EMR : $7.22B
EBITDA (TTM) JNJ : $31.62B EMR : $3.87B

Return for Risk

JNJ vs. EMR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

JNJ

JNJ Risk / Return Rank: 92
JNJ Sharpe Ratio Rank: 94
JNJ Sortino Ratio Rank: 95
JNJ Omega Ratio Rank: 93
JNJ Calmar Ratio Rank: 89
JNJ Martin Ratio Rank: 91

EMR

EMR Risk / Return Rank: 57
EMR Sharpe Ratio Rank: 61
EMR Sortino Ratio Rank: 55
EMR Omega Ratio Rank: 54
EMR Calmar Ratio Rank: 58
EMR Martin Ratio Rank: 58

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

JNJ vs. EMR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Johnson & Johnson (JNJ) and Emerson Electric Co. (EMR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	JNJ	EMR	Difference
Sharpe ratio Return per unit of total volatility	2.91	0.64	+2.27
Sortino ratio Return per unit of downside risk	4.26	1.06	+3.20
Omega ratio Gain probability vs. loss probability	1.52	1.13	+0.39
Calmar ratio Return relative to maximum drawdown	4.42	0.81	+3.61
Martin ratio Return relative to average drawdown	13.33	1.79	+11.53
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

JNJ vs. EMR - Sharpe Ratio Comparison

The current JNJ Sharpe Ratio is 2.91, which is higher than the EMR Sharpe Ratio of 0.64. The chart below compares the historical Sharpe Ratios of JNJ and EMR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	JNJ	EMR	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.91	0.64	+2.27
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.55	0.36	+0.19
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.54	0.46	+0.08
Sharpe Ratio (All Time) Calculated using the full available price history	0.53	0.34	+0.19

Drawdowns

JNJ vs. EMR - Drawdown Comparison

The maximum JNJ drawdown since its inception was -50.67%, smaller than the maximum EMR drawdown of -59.05%. Use the drawdown chart below to compare losses from any high point for JNJ and EMR.

Drawdown Indicators

	JNJ	EMR	Difference
Max Drawdown Largest peak-to-trough decline	-50.67%	-59.05%	+8.38%
Max Drawdown (1Y) Largest decline over 1 year	-10.96%	-23.45%	+12.49%
Max Drawdown (3Y) Largest decline over 3 years	-15.95%	-29.62%	+13.67%
Max Drawdown (5Y) Largest decline over 5 years	-18.41%	-29.62%	+11.21%
Max Drawdown (10Y) Largest decline over 10 years	-27.37%	-50.77%	+23.40%
Current Drawdown Current decline from peak	-9.67%	-12.18%	+2.51%
Average Drawdown Average peak-to-trough decline	-11.88%	-14.11%	+2.23%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.63%	10.59%	-6.96%

Volatility

JNJ vs. EMR - Volatility Comparison

The current volatility for Johnson & Johnson (JNJ) is 5.20%, while Emerson Electric Co. (EMR) has a volatility of 10.89%. This indicates that JNJ experiences smaller price fluctuations and is considered to be less risky than EMR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	JNJ	EMR	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.20%	10.89%	-5.69%
Volatility (6M) Calculated over the trailing 6-month period	12.17%	24.58%	-12.41%
Volatility (1Y) Calculated over the trailing 1-year period	16.67%	29.89%	-13.22%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	16.82%	27.22%	-10.40%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	18.45%	29.09%	-10.64%

Dividends

JNJ vs. EMR - Dividend Comparison

JNJ's dividend yield for the trailing twelve months is around 2.35%, more than EMR's 1.56% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
EMR Emerson Electric Co.	1.56%	1.61%	1.70%	2.14%	2.15%	2.18%	2.49%	2.58%	3.26%	2.76%	3.42%	3.94%
JNJ Johnson & Johnson	2.35%	2.48%	3.40%	3.00%	2.52%	2.45%	2.53%	2.57%	2.74%	2.38%	2.73%	2.87%

Financials

JNJ vs. EMR - Profitability Comparison

The chart below illustrates the profitability comparison between Johnson & Johnson and Emerson Electric Co. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

JNJ - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a gross profit of 17.20B and revenue of 24.06B. Therefore, the gross margin over that period was 71.5%.

EMR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Emerson Electric Co. reported a gross profit of 0.00 and revenue of 4.56B. Therefore, the gross margin over that period was 0.0%.

JNJ - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported an operating income of 6.40B and revenue of 24.06B, resulting in an operating margin of 26.6%.

EMR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Emerson Electric Co. reported an operating income of 0.00 and revenue of 4.56B, resulting in an operating margin of 0.0%.

JNJ - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a net income of 5.24B and revenue of 24.06B, resulting in a net margin of 21.8%.

EMR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Emerson Electric Co. reported a net income of 618.00M and revenue of 4.56B, resulting in a net margin of 13.6%.

Frequently Asked Questions

Can I hold both JNJ and EMR in my portfolio?

JNJ and EMR have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, JNJ or EMR?

EMR has higher volatility (10.89%) compared to JNJ (5.20%). In terms of maximum drawdown, JNJ dropped -50.67% vs EMR's -59.05%.

Which has better risk-adjusted returns?

JNJ currently has the higher Sharpe Ratio (2.91 vs 0.64), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.